The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Kura Oncology, Inc(NASDAQ:KURA) 
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. Its pipeline consists of small molecule product candidates that target cancer. The company's lead product candidates are tipifarnib, an orally bioavailable inhibitor ...
Website: http://www.kuraoncology.com
Founded: 2014
Full Time Employees: 83
CEO / Co-Founder: Troy Wilson
Sector: Healthcare
Industry: Biotechnology
Kura Oncology Days Payable Outstanding ttm (DPO)
Kura Oncology Days Receivable Outstanding ttm (DSO)
Kura Oncology Op Cashflow Per Share ttm
Kura Oncology Free Cashflow Per Share ttm
Kura Oncology Cash Per Share ttm
Kura Oncology P/S ratio ttm
Kura Oncology (GAAP) P/E ratio ttm
Kura Oncology P/B ratio ttm
No extra charts and metrics for this ticker.